⚠️
Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
Unresponsive to stimuli
10,939 total reports33.0% serious outcomes
Share
10,939
Total Reports
1,676
Deaths
1,938
Hospitalizations
33
Severity Rate
% serious outcomes
About Unresponsive to stimuli Reports
Unresponsive to stimuli has been reported 10,939 times in VAERS from 1990 to 2026.
Of these reports, 1,676 were associated with death (15.32%) and 1,938 involved hospitalization.
The overall serious outcome rate (death or hospitalization) for reports mentioning Unresponsive to stimuli is 33.0%.
Understanding Unresponsive to stimuli in VAERS
•Temporal association only: These reports show Unresponsive to stimuli occurred after vaccination, not necessarily because of vaccination.
•Background rates matter: Many symptoms occur naturally at baseline rates in the population, unrelated to vaccination.
•Reporting variability: Medical terminology may be used differently by various healthcare providers and over time.
•Investigation needed: High-frequency reports may trigger further epidemiological studies to determine causation.
What This Data Shows
Most Associated Vaccines: The vaccines most frequently mentioned in reports with Unresponsive to stimuli. This may reflect usage patterns, not causation.
Severity Patterns: The percentage of reports that involve serious outcomes can help prioritize safety investigations.
Reporting Trends: Changes in reporting frequency over time may reflect increased awareness, media attention, or actual safety signals.
Most Associated Vaccines
1. COVID197,545
2. MNQ658
3. HPV4645
4. HIBV633
5. TDAP620
6. HEPA578
7. FLU3538
8. MMR531
9. PNC13530
10. DTAP506
Quick Facts
Reports:10,939
Deaths:1,676
Hospitalizations:1,938
Mortality Rate:15.32%
Severity Rate:33.0%
Related Analysis
Explore Further
Data Source
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.